AHC, initially described by Verret and Steele in 1971 [7], represents a rare neurodevelopmental disorder primarily caused by de novo ATP1A3 pathogenic variants [2, 8]. This evidence concerns the gene ATP1A3 and alternating hemiplegia of childhood.